What is Genuity Science?
Headquartered in Ireland, Genuity Science provides a comprehensive suite of services tailored for the life sciences industry. Its offerings span critical areas such as sample processing, biobanking, nucleic acid extraction, quality control, and genotyping. Furthermore, the company leverages advanced technologies including next-generation sequencing and methylation profiling, culminating in robust data delivery solutions. This integrated approach positions Genuity Science as a key partner for research institutions and biotechnology firms.
How much funding has Genuity Science raised?
Genuity Science has raised a total of $620M across 4 funding rounds:
Series A
$15M
Series B
$165M
Unspecified
$240M
Series C
$200M
Series A (2013): $15M with participation from ARCH Venture Partners and Polaris Partners
Series B (2017): $165M led by Amgen Business Development, Sequoia China, Temasek, 3W Partners, and Yunfeng Capital
Unspecified (2017): $240M supported by Steamboat Ventures, Temasek, 3W Partners, and Yunfeng Capital
Series C (2018): $200M featuring Yunfeng Capital, Ireland Strategic Investment Fund, Temasek, and Steamboat Ventures
Key Investors in Genuity Science
Temasek
Temasek is a Singaporean state-owned investment company known for its long-term investment horizon and focus on a diverse range of sectors, including life sciences and technology.
Steamboat Ventures
Steamboat Ventures is the venture capital arm of The Walt Disney Company, often investing in technology and media companies, but also showing interest in innovative life science ventures.
Yunfeng Capital
Yunfeng Capital is a prominent Chinese private equity firm co-founded by Jack Ma, with a strong focus on technology, healthcare, and consumer sectors, indicating a strategic interest in Genuity Science's growth potential.
What's next for Genuity Science?
The recent major strategic investment signals a new phase of development for Genuity Science, likely focused on scaling its operations, expanding its technological capabilities, and potentially entering new markets. The company's trajectory, marked by consistent capital raises from significant backers, indicates a strong market demand for its specialized services in genomics and biobanking. Future endeavors may involve further integration of AI in data analysis or strategic partnerships to enhance its research and development pipeline.
See full Genuity Science company page
